verum.de

Name

verum.de

Legal name

verum.de GmbH

Website

https://verum.de

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Clinical Research Organization Services

NAICS

Scientific Research and Development Services (5417), Management Consulting Services (54161), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG)

Keywords

• Clinical trial management
• Contract research organization
• Regulatory affairs consulting
• Clinical monitoring services
• Gcp compliance auditing

Headquarters

HQ city

Germering

HQ country

Germany

HQ region

Europe

Offices10 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Clinical Trial Management Services: Comprehensive CRO services including consulting in medicinal product development strategy, study planning and allocation, regulatory affairs, feasibility and investigator/site selection, regulatory and EC submissions, international and local project management, monitoring, medical monitoring, medical and regulatory writing, safety surveillance, legal and financial advising, study budget planning, contracts and payments, and GCP audits. Services can be engaged as standalone offerings or combined into fully tailored client packages.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

verum.de GmbH is a Central and Eastern Europe-focused Contract Research Organization (CRO) providing end-to-end clinical trial consulting and operational services to pharmaceutical, biotech, and medical device sponsors. Offerings span the full trial lifecycle — study planning and feasibility, regulatory and ethics committee submissions, project management, clinical monitoring (CTA/CRA/PM), medical monitoring, medical and regulatory writing, safety surveillance, GCP audits, and legal/financial/contract services — delivered as standalone offerings or integrated, tailored client packages across 14+ therapeutic areas.

Product overview

Verum is a Contract Research Organization (CRO) offering a comprehensive portfolio of clinical trial consulting and operational services across Western, Central, and Eastern Europe. The company's core offerings include Clinical Trial Management and Operations (project management, monitoring, CRA/CTA/PM services, medical monitoring), Regulatory Affairs Consulting (strategy, planning, submissions), Medical and Regulatory Writing, Safety Surveillance, Feasibility and Site Selection, GCP Audits, and Legal/Financial/Contract Services. These services are delivered as standalone offerings or combined into fully tailored client packages. The company specializes in therapeutic areas including cardiovascular diseases, neurology, oncology, respiratory diseases, endocrinology, psychiatry, infectious diseases, and dermatology. Verum operates through a partnership network with data management, biostatistics, IMP packaging, and logistics companies, and is a member of the ACE-React network of clinical trial service suppliers.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Management and Operations End-to-end clinical trial operational services including international and local project management, clinical trial monitoring provided by CRAs and CTAs, and medical monitoring, delivered for pharmaceutical, biotech, and medical device sponsors across Europe.
• Regulatory Affairs Consulting Consulting services covering medicinal product development strategy, study planning and allocation, regulatory submissions to authorities and ethics committees, and compliance with regulatory requirements across 10+ jurisdictions in Central and Eastern Europe.
• Medical and Regulatory Writing Professional medical writing and regulatory documentation services to support clinical trial conduct and regulatory submissions for sponsors.
• Safety Surveillance Comprehensive safety monitoring and pharmacovigilance services for clinical trials to ensure compliance with safety reporting requirements.
• Feasibility and Investigator/Site Selection Site identification, feasibility assessments, and investigator selection services to optimize clinical trial recruitment and execution across Central and Eastern Europe.
• GCP Audits and Quality Assurance Clinical trial consulting and Good Clinical Practice (GCP) audits to ensure compliance with international standards and regulatory requirements, underpinned by an ISO-based Quality Management System with comprehensive SOPs, policies, and experienced QA personnel.
• Legal, Financial and Contract Services Legal and financial advising for clinical trial conduct, study budget planning, contracts management, and payment processing services for clinical trial sponsors.
• Therapeutic Area Expertise Specialized clinical trial services across 14+ therapeutic areas including cardiovascular, neurology, oncology, respiratory, endocrinology, psychiatry, infectious diseases, dermatology, and additional specialties, leveraging long-standing investigator networks in CEE countries.

Quantifiable outcome

• 47 regulatory authority inspections (including FDA and EMA) completed without critical findings
• +4 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered core.

• ACE-React NetworkcoreStrategic or Co-development PartnerVerum is a member of the ACE-React network of clinical trial services suppliers. ACE-React provides a network of CT services suppliers for collaborative clinical trial operations.
• Data Management CompaniescoreTechnology or IntegrationPartnership network established to provide single-contract, robust, and highly competent service for clients through integrated data management solutions.
• Biostatistics CompaniescoreTechnology or IntegrationPartnership network providing comprehensive biostatistics services integrated with Verum's clinical trial management offerings.
• IMP Packaging CompaniescoreTechnology or IntegrationPartnership network for investigational medicinal product (IMP) packaging services as part of comprehensive clinical trial support.
• Logistics CompaniescoreTechnology or IntegrationPartnership network providing logistics services to support clinical trial operations across multiple countries.

Scale indicators10 records

Recent moves12 records

Expansion highlights6 records

Emerging players

• Medpace: Mid-size, scientifically led CRO with strong therapeutic-area specialization in oncology and cardiometabolic; comparable mid-cap profile and full-service model, though more tech-forward and US-headquartered.
• Clinipace Worldwide: Mid-size, tech-enabled CRO with comparable therapeutic-area and oncology trials portfolio; an emerging peer representative of the technology-augmented service model Verum's QMS-led approach must increasingly compete against.

Direct peers

• TFS International: Swedish privately held mid-size CRO with full-service clinical and biometrics capabilities across Europe; structurally and operationally similar to Verum in size, service mix, and biotech/pharma sponsor focus.
• PSI CRO AG: Privately held, Switzerland-headquartered mid-size CRO with comparable full-service clinical operations across Europe and similar ownership-controlled structure; most directly comparable in size, geographic mix, and service scope to Verum.
• Worldwide Clinical Trials: Privately held, mid-size global CRO with comparable therapeutic-area depth and full-service clinical operations; a close scale and operating-model analog to Verum for sponsor-side vendor selection.
• PROMEDICA International Group: Regional Central and Eastern European CRO with clinical operations and monitoring capabilities in Poland and neighboring countries; the most explicit CEE-focused peer to Verum in geographic concentration.

Broad incumbents

• Parexel International: Global full-service CRO with deep biotech sponsor relationships; relevant as a comparator for the full lifecycle consulting-plus-operations service model Verum also offers to pharma/biotech clients.
• ICON plc: Top-3 global CRO with broad European coverage and post-PRA Health Sciences scale advantages; relevant benchmark for full-service, multi-region clinical trial delivery models Verum competes within.
• IQVIA: Largest global CRO with significant CEE hub-and-spoke operations; relevant as the mega-scale competitor whose pricing and sponsor relationships set the baseline Verum must meet or differentiate against.
• Syneos Health: Large global full-service CRO with established operations across Central and Eastern Europe; competes with Verum for multi-country European trial mandates but also frequently subcontracts regional monitoring to specialists like Verum.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/verum.de

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about verum.de